Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 7081-7088 |
Number of pages | 8 |
Journal | Journal of Clinical Oncology |
Volume | 23 |
Issue number | 28 |
DOIs | |
Publication status | Published - 2005 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre. / Bontenbal, Marijke; Creemers, GJ; Braun, HJ; de Boer, AC; Janssen, JT; Leys, RB; Ruit, JB; Goey, SH (Swan Hoo); van der Velden, PC; Kerkhofs, LG; Schothorst, KL; Schmitz, PI; Bokma, HJ; Verweij, Jaap; Seynaeve, Caroline.
In: Journal of Clinical Oncology, Vol. 23, No. 28, 2005, p. 7081-7088.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre
AU - Bontenbal, Marijke
AU - Creemers, GJ
AU - Braun, HJ
AU - de Boer, AC
AU - Janssen, JT
AU - Leys, RB
AU - Ruit, JB
AU - Goey, SH (Swan Hoo)
AU - van der Velden, PC
AU - Kerkhofs, LG
AU - Schothorst, KL
AU - Schmitz, PI
AU - Bokma, HJ
AU - Verweij, Jaap
AU - Seynaeve, Caroline
PY - 2005
Y1 - 2005
U2 - 10.1200/JCO.2005.06.236
DO - 10.1200/JCO.2005.06.236
M3 - Article
VL - 23
SP - 7081
EP - 7088
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
SN - 0732-183X
IS - 28
ER -